Peter A C Maple (Peter Maple, Peter A Maple, P A C Maple)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 11

Top Topics

Diffuse Large B Cell Lymphoma

Herpes Simplex Virus

Multiple Sclerosis

Top Venues

Pathogens (Basel, Switzerland)

Epidemiology and infection

Neurology international

This page only lists publications with an associated author ORCID identifier.

Publications

Peter A C Maple, Radu Tanasescu, Cris S Constantinescu, Paola Valentino, Marco Capobianco, Silvia D'Orso, Giovanna Borsellino, Luca Battistini, Giovanni Ristori, Rosella Mechelli, Marco Salvetti, Bruno Gran
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. Pathogens (Basel, Switzerland) 13 (6) (2024)
Peter A C Maple, Radu Tanasescu, Cris S Constantinescu, Paola Valentino, Marco Capobianco, Silvia D'Orso, Giovanna Borsellino, Luca Battistini, Giovanni Ristori, Rosella Mechelli, Marco Salvetti, Bruno Gran
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. Pathogens (Basel, Switzerland) 13 (6) (2024)
Peter A C Maple, Radu Tanasescu, Cris S Constantinescu, Paola Valentino, Marco Capobianco, Silvia D'Orso, Giovanna Borsellino, Luca Battistini, Giovanni Ristori, Rosella Mechelli, Marco Salvetti, Bruno Gran
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. Pathogens (Basel, Switzerland) 13 (6) (2024)
Peter A C Maple
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections. Vaccines 11 (2) (2023)
Peter A C Maple
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections. Vaccines 11 (2) (2023)
Stefano Petrini, Peter A C Maple
Herpesvirus Vaccines. Vaccines 10 (4) (2022)
Peter A C Maple
Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective. Vaccines 9 (6) (2021)
Peter A C Maple
Multiple Sclerosis, Viruses, and New Vaccines. Neurology international 13 (4) (2021)
Peter A C Maple
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development. Vaccines 8 (1) (2020)
Peter A C Maple, Bruno Gran, Radu Tanasescu, David I Pritchard, Cris S Constantinescu
An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination. Vaccines 8 (3) (2020)
Peter A C Maple, J Haedicke, M Quinlivan, S P Steinberg, A A Gershon, K E Brown, J Breuer
The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay. Epidemiology and infection 144 (11) (2016)